aminopentamide,
aminopentamide, (+-)-isomer,
aminopentamide, sulfate,
Aminopentamide,
Dimevamide,
60-46-8,
4-(dimethylamino)-2,2-diphenylpentanamide,
Dimevamida,
Dimevamidum,
UNII-IP1B47L61M,
Valeramide-OM,
dl-Aminopentamide,
Dimevamide [INN],
Dimevamidum [INN-Latin],
Dimevamida [INN-Spanish],
Dimevamid,
IP1B47L61M,
EINECS 200-479-8,
(+)-Aminopentamide,
(?)-Aminopentamide,
BL 139,
4-Dimethylamino-2,2-diphenylvaleramide,
AC1L2KME,
alpha,alpha-Diphenyl-gamma-dimethylaminovaleramide,
CHEMBL92915,
SCHEMBL251458,
Aminopentamide sulfate(200 mg),
DTXSID2057605,
CHEBI:91829,
Benzeneacetamide, alpha-(2-(dimethylamino)propyl)-alpha-phenyl-,
BL-139,
MFCD00865194,
SBI-0206820.P001,
X4884,
Valeramide, 4-(dimethylamino)-2,2-diphenyl-,
AB01563100_01,
BRD-A69917777-065-01-4,
alpha-(2-(Dimethylamino)propyl)-alpha-phenylbenzeneacetamide,
alpha-(2-(Dimethylamino)propyl)-alpha-phenylbenzeneacetamide sulfate,
Centrine,
Valeramide,
Aminopentamide sulfate,
dimevamid-,
AMINOPENTAMIDESULFATE,
C19H24N2O,
CID22565,
C19-H24-N2-O,
AMINOPENTAMIDE SULFATE (200 MG),
Valeramide, 4-(dimethylamino)-2,2-diphenyl-, (.+.)-,
alpha-[2-(Dimethylamino)propyl]-alpha-phenylbenzeneacetamide,
Benzeneacetamide, alpha-[2-(dimethylamino)propyl]-alpha-phenyl-,
Benzeneacetamide, .alpha.-[2-(dimethylamino)propyl]-.alpha.-phenyl-, (.+.)-,